Literature DB >> 14981603

Optimum dietary protein requirement in nondiabetic maintenance hemodialysis patients.

Sakae Ohkawa1, Yukiko Kaizu, Mari Odamaki, Naoki Ikegaya, Ikuo Hibi, Kunihiko Miyaji, Hiromichi Kumagai.   

Abstract

BACKGROUND: There is controversy about whether the dietary protein requirement of 1.2 g/kg/d for hemodialysis (HD) patients, in the nutritional guidelines recommended by the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-KDOQI), is reasonable.
METHODS: A cross-sectional study was conducted in 129 stable HD patients without diabetes (84 men, 45 women) to investigate the association between the protein equivalent of nitrogen appearance normalized by ideal body weight (nPNAibw), an index of protein intake, and skeletal muscle mass or other metabolic consequences. Patients were divided into 5 groups according to nPNAibw index. Midthigh muscle area (TMA), midthigh subcutaneous fat area (TSFA), abdominal muscle area (AMA), abdominal subcutaneous fat area (ASFA), and visceral fat area (AVFA) were measured using computed tomography, and various nutritional parameters were compared among these groups.
RESULTS: TMA and AMA values increased with increasing dietary protein intake from less than 0.7 g/kg/d to 0.9-1.1 g/kg/d and showed a plateau at greater than 0.9 to 1.1 g/kg/d of dietary protein intake. Conversely, fat mass, including TSFA, ASFA, and AVFA, and serum potassium concentration increased with graded protein intake, and no plateau was formed. Patients with nPNAibw greater than 1.3 g/kg/d satisfied the criterion of visceral obesity. Although serum prealbumin levels showed a trend similar to that of muscle mass, there was no significant difference in serum albumin levels among the study groups.
CONCLUSION: Optimal dietary protein requirement for patients undergoing maintenance HD in a stable condition appears to be less than the level recommended by the NKF-KDOQI nutritional guidelines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14981603     DOI: 10.1053/j.ajkd.2003.10.042

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Lower thigh muscle mass is associated with all-cause and cardiovascular mortality in elderly hemodialysis patients.

Authors:  H Fukasawa; M Kaneko; H Niwa; T Matsuyama; H Yasuda; H Kumagai; R Furuya
Journal:  Eur J Clin Nutr       Date:  2016-10-19       Impact factor: 4.016

Review 2.  Clinical research in a modern Chinese peritoneal dialysis center.

Authors:  Jie Dong; Ming-hui Zhao
Journal:  Perit Dial Int       Date:  2014-06       Impact factor: 1.756

Review 3.  Methods and Nutritional Interventions to Improve the Nutritional Status of Dialysis Patients in JAPAN-A Narrative Review.

Authors:  Yoshihiko Kanno; Eiichiro Kanda; Akihiko Kato
Journal:  Nutrients       Date:  2021-04-21       Impact factor: 5.717

Review 4.  An update on nutrition in chronic kidney disease.

Authors:  Denis Fouque; Fitsum Guebre-Egziabher
Journal:  Int Urol Nephrol       Date:  2006-11-24       Impact factor: 2.266

5.  Impact of nutritional index on the association between phosphorus concentrations and mortality in haemodialysis patients: a cohort study from dialysis outcomes and practice pattern study in Japan.

Authors:  Shingo Fukuma; Tatsuyoshi Ikenoue; Tadao Akizawa; Shunichi Fukuhara
Journal:  BMJ Open       Date:  2017-08-07       Impact factor: 2.692

6.  Effects of keto acid supplements on Chinese patients receiving maintenance hemodialysis: a prospective, randomized, controlled, single-center clinical study.

Authors:  Hai-Long Li; Hui Li; Yi-Fu Cao; Yue Qi; Wei-Qi Wang; Shi-Qin Liu; Chen-Die Yang; Xiao-Yan Yu; Tao Xu; Yan Zhu; Wei Chen; Jian-Ling Tao; Xue-Wang Li
Journal:  Chin Med J (Engl)       Date:  2020-01-05       Impact factor: 2.628

7.  The Impact of Serum Zinc Levels on Abdominal Fat Mass in Hemodialysis Patients.

Authors:  Hirotaka Fukasawa; Hiroki Niwa; Kento Ishibuchi; Mai Kaneko; Takamasa Iwakura; Hideo Yasuda; Ryuichi Furuya
Journal:  Nutrients       Date:  2020-02-28       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.